Clinical Trials Logo

Filter by:
NCT ID: NCT03154125 Not yet recruiting - Contraception Clinical Trials

Sayana® Press Extension Study

Start date: July 30, 2017
Phase: Phase 3
Study type: Interventional

This is a randomized clinical trial designed to evaluate the effectiveness, safety and acceptability of Sayana® Press when injected every 4 months (17-18 weeks) for 3 treatment cycles (12 months) of use.

NCT ID: NCT03107611 Recruiting - Atopic Dermatitis Clinical Trials

Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis

Start date: February 29, 2016
Phase: Phase 3
Study type: Interventional

To establish the bioequivalence between test drug, Pimecrolimus Cream, 1% with that of reference listed drug, Elidel® (pimecrolimus) Cream 1%, in the treatment of mild to moderate Atopic Dermatitis. To establish superiority of each active treatment over the placebo.

NCT ID: NCT03021499 Recruiting - Lupus Nephritis Clinical Trials

Aurinia Renal Response in Active Lupus With Voclosporin

AURORA
Start date: May 17, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy of voclosporin compared with placebo in achieving renal response after 52 weeks of therapy in subjects with active lupus nephritis.

NCT ID: NCT03005964 Recruiting - Plaque Psoriasis Clinical Trials

Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis

Start date: December 2016
Phase: Phase 2
Study type: Interventional

To compare the safety and efficacy profiles of AM001 Cream, 7.5% and its vehicle cream in the treatment of plaque psoriasis

NCT ID: NCT02943070 Active, not recruiting - Clinical trials for Benign Prostatic Hyperplasia

Rezum I Pilot Study for BPH

Rezum Pilot
Start date: March 2012
Phase: N/A
Study type: Interventional

Evaluate the safety and efficacy of the Rezum System for the treatment of BPH

NCT ID: NCT02940392 Active, not recruiting - Clinical trials for Benign Prostatic Hyperplasia

Rezum FIM Optimization

Rezum FIM
Start date: February 2012
Phase: N/A
Study type: Interventional

Evaluate the effect of the NxThera BPH Rezum System on prostate tissue in subjects suffering from LUTS symptoms secondary to benign prostatic hyperplasia (BPH).

NCT ID: NCT02904369 Recruiting - HIV Clinical Trials

PK and PD Study of Oral F/TAF for HIV Prevention

Start date: October 2016
Phase: Phase 1
Study type: Interventional

This multi-center Phase I study is designed to characterize the PK and PD of F/TAF oral tablets to assess systemic and genital tract bioavailability in healthy women. The oral tablets to be used in the study are F/TAF (200/10 mg), F/TAF (200/25 mg) and F/TDF (200/300 mg, Truvada). Samples will be obtained before, during and after dosing in two study phases.

NCT ID: NCT02860052 Active, not recruiting - Tinea Pedis Clinical Trials

SB208 for the Treatment of Tinea Pedis

Start date: July 2016
Phase: Phase 2
Study type: Interventional

This is a phase 2, multi-center, double-blind, randomized, vehicle-controlled study to be conducted in approximately 170 non immunocompromised adult subjects with interdigital tinea pedis. Subjects will apply the investigational product (IP) (SB208 or Vehicle Gel) to the interdigital areas and all affected and immediate surrounding areas of one or both feet once daily for 2 weeks, followed by a 4-week post-treatment observation period.

NCT ID: NCT02812771 Recruiting - Onychomycosis Clinical Trials

Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis

Start date: June 2016
Phase: Phase 4
Study type: Interventional

Safety and PK of a once daily topical application of efinaconazole in the treatment of pediatric subjects with mild to severe onychomycosis of the toenails.

NCT ID: NCT02796066 Withdrawn - Acne Vulgaris Clinical Trials

TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris

Start date: June 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and effectiveness of TSN 2898 topical gel in the treatment of moderate to severe acne.